Literature DB >> 22402031

BK polyomavirus: emerging pathogen.

Shauna M Bennett1, Nicole M Broekema, Michael J Imperiale.   

Abstract

BK polyomavirus (BKPyV) is a small double-stranded DNA virus that is an emerging pathogen in immunocompromised individuals. BKPyV is widespread in the general population, but primarily causes disease when immune suppression leads to reactivation of latent virus. Polyomavirus-associated nephropathy and hemorrhagic cystitis in renal and bone marrow transplant patients, respectively, are the most common diseases associated with BKPyV reactivation and lytic infection. In this review, we discuss the clinical relevance, effects on the host, virus life cycle, and current treatment protocols.
Copyright © 2012 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22402031      PMCID: PMC3568954          DOI: 10.1016/j.micinf.2012.02.002

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  114 in total

1.  Fatal BK polyoma viral pneumonia associated with immunosuppression.

Authors:  Anjela Galan; Carol A Rauch; Christopher N Otis
Journal:  Hum Pathol       Date:  2005-09       Impact factor: 3.466

2.  BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients.

Authors:  Veronique Erard; Hyung Woo Kim; Lawrence Corey; Ajit Limaye; Meei-Li Huang; David Myerson; Chris Davis; Michael Boeckh
Journal:  Blood       Date:  2005-04-21       Impact factor: 22.113

3.  Ultrastructural aspects of BK virus uptake and replication in human fibroblasts.

Authors:  N M Maraldi; G Barbanti-Brodano; M Portolani; M La Placa
Journal:  J Gen Virol       Date:  1975-04       Impact factor: 3.891

Review 4.  Human polyomavirus JC and BK persistent infection.

Authors:  Kristina Doerries
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Inhibition of BK virus haemagglutination by gangliosides.

Authors:  L Sinibaldi; D Viti; P Goldoni; G Cavallo; C Caroni; N Orsi
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

Review 6.  Update on new antivirals under development for the treatment of double-stranded DNA virus infections.

Authors:  L K Dropulic; J I Cohen
Journal:  Clin Pharmacol Ther       Date:  2010-09-29       Impact factor: 6.875

7.  Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients.

Authors:  A I Sánchez Fructuoso; N Calvo; I Perez-Flores; R Valero; B Rodríguez-Sánchez; D García de Viedma; P Muñoz; A Barrientos
Journal:  Transpl Infect Dis       Date:  2011-05-17       Impact factor: 2.228

8.  Control of protein phosphatase 2A by simian virus 40 small-t antigen.

Authors:  S I Yang; R L Lickteig; R Estes; K Rundell; G Walter; M C Mumby
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

9.  Treatment of renal allograft polyoma BK virus infection with leflunomide.

Authors:  Michelle A Josephson; Daniel Gillen; Basit Javaid; Pradeep Kadambi; Shane Meehan; Preston Foster; Robert Harland; Richard J Thistlethwaite; Marc Garfinkel; Walter Atwood; Joslynn Jordan; Molly Sadhu; Michael J Millis; James Williams
Journal:  Transplantation       Date:  2006-03-15       Impact factor: 4.939

Review 10.  Common and unique features of T antigens encoded by the polyomavirus group.

Authors:  J M Pipas
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

View more
  45 in total

1.  Replication of oral BK virus in human salivary gland cells.

Authors:  Raquel Burger-Calderon; Victoria Madden; Ryan A Hallett; Aaron D Gingerich; Volker Nickeleit; Jennifer Webster-Cyriaque
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

2.  A short tale of blood, kidney and brain: BK virus encephalitis in an allogeneic stem cell transplant recipient.

Authors:  C Bourlon; S Alamoudi; D Kumar; A Viswabandya; S Thyagu; F V Michelis; D D-H Kim; J H Lipton; H A Messner; U Deotare
Journal:  Bone Marrow Transplant       Date:  2017-02-20       Impact factor: 5.483

3.  Simian virus 40 large T antigen induces IFN-stimulated genes through ATR kinase.

Authors:  Adriana Forero; Nicholas S Giacobbi; Kevin D McCormick; Ole V Gjoerup; Christopher J Bakkenist; James M Pipas; Saumendra N Sarkar
Journal:  J Immunol       Date:  2014-05-05       Impact factor: 5.422

Review 4.  More than just oncogenes: mechanisms of tumorigenesis by human viruses.

Authors:  Marta M Gaglia; Karl Munger
Journal:  Curr Opin Virol       Date:  2018-09-27       Impact factor: 7.090

5.  Early identification of renal transplant recipients with high risk of polyomavirus-associated nephropathy.

Authors:  K Teutsch; F Schweitzer; E Knops; R Kaiser; H Pfister; J Verheyen; H Göbel; T Cingöz; V Di Cristanziano
Journal:  Med Microbiol Immunol       Date:  2015-03-07       Impact factor: 3.402

6.  The risk of polyomavirus BK-associated hemorrhagic cystitis after allogeneic hematopoietic SCT is associated with myeloablative conditioning, CMV viremia and severe acute GVHD.

Authors:  J Uhm; N Hamad; F V Michelis; M Shanavas; J Kuruvilla; V Gupta; J H Lipton; H A Messner; M Seftel; D D Kim
Journal:  Bone Marrow Transplant       Date:  2014-08-11       Impact factor: 5.483

7.  BK Polyomavirus Activates the DNA Damage Response To Prolong S Phase.

Authors:  Joshua L Justice; Jason M Needham; Sunnie R Thompson
Journal:  J Virol       Date:  2019-06-28       Impact factor: 5.103

8.  BK polyomavirus subtype III in a pediatric renal transplant patient with nephropathy.

Authors:  Beatrix Kapusinszky; Sharon F Chen; Malaya K Sahoo; Martina I Lefterova; Lynn Kjelson; Paul C Grimm; Neeraja Kambham; Waldo Concepcion; Benjamin A Pinsky
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

9.  Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani population.

Authors:  Iqra Hussain; Fareeda Tasneem; Muhammed Umer; Ayesha Pervaiz; Muslim Raza; Muhammad Imran Arshad; Naveed Shahzad
Journal:  Virol J       Date:  2017-04-24       Impact factor: 4.099

10.  Peptide immunization elicits polyomavirus-specific MHC class ib-restricted CD8 T cells in MHC class ia allogeneic mice.

Authors:  Amelia R Hofstetter; Brian D Evavold; Aron E Lukacher
Journal:  Viral Immunol       Date:  2013-02-01       Impact factor: 2.257

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.